newsfilter
← Latest News
PR Newswire·

AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

Request for Emergency Use Authorization of Niyad™ submitted to the FDA in April Divestment of DSUVIA® to Alora Pharmaceuticals closed April 3, 2023 $13.4 million in cash as of March 31, 2023 Webcast and